Early decrease of an epidemic: Evolution of the prevalence of HIV, hepatitis B, hepatitis C and aminotransferases among intravenous drug users in Strasbourg between 1980 and 1990;Decroissance precoce d'une epidemie: Evolution des prevalences du VIH, VHB, VHC et des aminotransferases chez les toxicomanes intraveineux a Strasbourg entre 1980 et 1990

Revue Medicale de la Suisse Romande

Volumn 119, Issue 4, 1999, Pages 329-334

  Will, Thomas ^a  

^a Division d'Abus de Substances   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; AMINOTRANSFERASE; BIOLOGICAL MARKER;

ADULT; ARTICLE; DRUG ABUSE; EPIDEMIC; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; VIRUS HEPATITIS; VIRUS INFECTION; VIRUS TRANSMISSION; BLOOD; ENZYMOLOGY; FRANCE; HEALTH; HEALTH SURVEY; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SUBSTANCE ABUSE;

ADULT; BIOLOGICAL MARKERS; FEMALE; FRANCE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; MALE; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TRANSAMINASES; URBAN HEALTH;

EID: 0033111816     PISSN: 00353655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Costes J.M.: La toxicomanie: un difficile passage àl'âge adulte? In La toxicomanie, Ministère de la santé, Sesi, documentation française, 258-261, 1990.
2. Mongin O., Olievenstein C, Barzach M.: Ingérences toxicomanie sida. Médecins du monde, Paris, 2: 91 pp., 1994.
3. Kessler V, Ungerer C.: Les indicateurs de la toxicomanie en Alsace. ORSAL, 57 pp., 1991.
4. Coumaros D., Carnéira de Castro E., Lehr D.: La prise en charge des usagers de drogues pour sevrage dans un service de médecine. S. Med. Strasbourg, 24 (7-9): 238-242, 1993.
5. Espinoza P., Bouchard I., Buffet C.: Forte prévalence de l'infection par le virus de l'hépatite B et le virus HIV chez les usagers de drogues français incarcérés. Castroentérol. Clin. Biol., 11: 288-292, 1987.
6. Ingold F.R., Ingold S., Jacob C.: La transmission du VIH chez les usagers de drogues, pratiques, attitudes et représentation: situation et tendance. Institut de recherche en épidémiologie de la pharmacodépendance. Paris, p. 53, mars 1992.
7. Buning E.G., Coutinho R.A., Van Brussel G.H.A., Van Santen C.W., Van Zadelhoff A.W.: Preventing AIDS in drug addicts in Amsterdam [letter]. Lancet, i: 1435, 1986.
8. Bulletin Epidémiologique Hebdomadaire: Surveillance du Sida en France, situation le 31 mars 1994. 19: 81-87, 1994.
9. Weissing L.G., Houweling J., Spruit I.P. et al.: HIV among drug users in regional towns near the initial focus of the Dutch epidemic [letter]. AIDS, 10-12: 1448-1449, 1996.
10. Janot C., Couroucé A., Boudard D. et al.: Etude analytique des trousses de dépistage et de confirmation des anticorps anti-VHC Abbott et Ortho. Revue Française de Transfusion et d'Hémobiologie, 35: 171-182, 1992.
11. Van der Poel C., Cuypers H., Reesink H.W.: Confirmation of hepatitis C virus infection by new four antigen recombinant immunoblot assay. Lancet, 337: 317-319, 1991.
12. Woodfield C., Harness M., Rix-Trott K.: Hepatitis C virus infection in oral and injectable drug users. New Zeeland Medical Journal, 106 (961): 332-334, 1993.
13. Buning E.G.: Effects of Amsterdam needle and syringe exchange. The international Journal of the Addictions, 26 (12): 1303-1311, 1991.
14. Kunches L., Craven D., Werner B.: Seroprevalence of hepatitis B and delta agent in parenteral drug abusers. Immunogenicity of hepatitis B vaccine. Am. J. Med., 312: 521-524, 1985.
15. Botti O., Pistelli A., Gambassi F. et al.: HBV and HCV infection in i.v. drug addicts; coinfection with HIV. Arch. Virol., 4 (suppl.): 329-332, 1992.
16. Cacopardo B., Fatuzzo F., Cosentino S. et al.: HCV and HIV infection among intravenous drug abusers in Eastern Sicily. Arch. Virol., 4 (suppl.): 333-334, 1992.
17. Chamot E., De Saussure P., Hirschel B., Déglon J.J., Perrin L.H.: Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance program. AIDS, 6 (4): 430-431, 1992.
18. Westh H., Worm A.M., Jensen B.L. et al.: Hepatitis C Virus Antibodies in Homosexual Men and Intravenous Drug Users in Danmark. Infection, 21 (2): 115-117, 1993.
19. Patti A.M., Santi A.L., Pompa M.G. et al.: Viral Hepatitis and Drugs: A Continuing Problem. International journal of Epidemiology, 22 (1): 135-139, 1993.